Cancer Testis Antigen (CTA) T21, as a Potential Diagnostic, Prognostic, and Immune-Therapeutic Targets for Malignant Tumours. Journal of Medical Sciences, [S. l.], v. 17, n. 1, p. 1–7, 2022. DOI: 10.51984/joms.v17i1.1892. Disponível em: http://sebhau.edu.ly/journal/joms/article/view/1892. Acesso em: 30 jan. 2026.